Duolingo, Inc. (NASDAQ:DUOL – Get Free Report) CFO Matthew Skaruppa sold 8,000 shares of the stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $218.39, for a total transaction of $1,747,120.00. Following the sale, the chief financial officer now directly owns 64,523 shares of the company’s stock, valued at approximately $14,091,177.97. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
Matthew Skaruppa also recently made the following trade(s):
- On Friday, March 1st, Matthew Skaruppa sold 8,000 shares of Duolingo stock. The stock was sold at an average price of $235.18, for a total transaction of $1,881,440.00.
- On Thursday, February 1st, Matthew Skaruppa sold 8,000 shares of Duolingo stock. The shares were sold at an average price of $178.67, for a total transaction of $1,429,360.00.
Duolingo Stock Performance
Shares of DUOL opened at $220.03 on Thursday. The company has a debt-to-equity ratio of 0.03, a current ratio of 3.24 and a quick ratio of 3.24. The stock has a market capitalization of $9.43 billion, a PE ratio of 647.15 and a beta of 0.83. Duolingo, Inc. has a 12-month low of $116.82 and a 12-month high of $245.87. The business’s fifty day moving average price is $204.09 and its 200 day moving average price is $197.21.
Analyst Ratings Changes
DUOL has been the subject of several recent research reports. Needham & Company LLC increased their price objective on shares of Duolingo from $210.00 to $241.00 and gave the company a “buy” rating in a research report on Thursday, February 29th. Bank of America increased their target price on Duolingo from $230.00 to $260.00 and gave the company a “neutral” rating in a research note on Thursday, February 29th. Piper Sandler increased their target price on Duolingo from $217.00 to $282.00 and gave the company an “overweight” rating in a research note on Thursday, February 29th. Barclays increased their target price on Duolingo from $173.00 to $243.00 and gave the company an “equal weight” rating in a research note on Thursday, February 29th. Finally, The Goldman Sachs Group increased their target price on Duolingo from $160.00 to $190.00 and gave the company a “sell” rating in a research note on Thursday, February 29th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $235.11.
Check Out Our Latest Analysis on Duolingo
Institutional Investors Weigh In On Duolingo
A number of hedge funds have recently added to or reduced their stakes in DUOL. Discovery Value Fund bought a new stake in Duolingo in the fourth quarter valued at $27,000. Bamco Inc. NY bought a new stake in Duolingo in the third quarter valued at $39,000. FSC Wealth Advisors LLC acquired a new position in shares of Duolingo during the fourth quarter valued at $39,000. Captrust Financial Advisors increased its holdings in shares of Duolingo by 620.8% during the first quarter. Captrust Financial Advisors now owns 555 shares of the company’s stock valued at $53,000 after purchasing an additional 478 shares during the period. Finally, Lazard Asset Management LLC acquired a new position in shares of Duolingo during the fourth quarter valued at $58,000. 91.59% of the stock is currently owned by institutional investors.
Duolingo Company Profile
Duolingo, Inc operates as a mobile learning platform in the United States, the United Kingdom, and internationally. The company offers courses in 40 different languages, including Spanish, English, French, German, Italian, Portuguese, Japanese, and Chinese through its Duolingo app. It also provides a digital English language proficiency assessment exam.
Featured Articles
- Five stocks we like better than Duolingo
- Upcoming IPO Stock Lockup Period, Explained
- What is a Bull Market? Key Information about Bull Markets
- Why Invest in 5G? How to Invest in 5G Stocks
- Akebia Therapeutics Surges on FDA Approval for Anemia Treatment
- The Most Important Warren Buffett Stock for Investors: His Own
- Dave & Buster’s Stock Value Is Unleashed, Not Too Late To Get In
Receive News & Ratings for Duolingo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Duolingo and related companies with MarketBeat.com's FREE daily email newsletter.